Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas

Endocrine Pathology

Volumn 21, Issue 3, 2010, Pages 166-177

  Juhlin, C Christofer ^a   Nilsson, Inga Lena ^a   Johansson, Kenth ^b   Haglund, Felix ^a   Villablanca, Andrea ^a   Höög, Anders ^a   Larsson, Catharina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Västervik Hospital   (Sweden)

Author keywords

APC; Atypical parathyroid adenoma; HRPT2; Immunohistochemistry; Parafibromin; Parathyroid carcinoma

Indexed keywords

APC PROTEIN; PARAFIBROMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 77956460947     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-010-9121-z     Document Type: Article

References (23)

1. E Shane 2001 Clinical review 122: parathyroid carcinoma J Clin Endocrinol Metab 86 485 493 10.1210/jc.86.2.485 1:CAS:528:DC%2BD3MXht1Kns78%3D 11157996 (Pubitemid 32207447)
2. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of the tumours of endocrine organs. In DeLellis RA, Lloyd RV, Heitz PU and Eng C, ed. WHO classification of tumours. Lyon: IARC Press, 2006; 124-127.
3. K Sandelin O Tullgren LO Farnebo 1994 Clinical course of metastatic parathyroid cancer World J Surg 18 594 598 10.1007/BF00353773 1:STN:280:DyaK2M3kt1Ortw%3D%3D 7725750
4. G Ippolito FF Palazzo F Sebag, et al. 2007 Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma Br J Surg 94 566 570 10.1002/bjs.5570 1:STN:280:DC%2BD2s3ks1ektg%3D%3D 17380564 (Pubitemid 46732239)
5. RA DeLellis 2008 Challenging lesions in the differential diagnosis of endocrine tumours: parathyroid carcinoma Endocr Pathol 19 221 225 10.1007/s12022-008-9050-2 1:CAS:528:DC%2BD1MXksFOnsQ%3D%3D 19058032
6. SE Rodgers ND Perrier 2006 Parathyroid carcinoma Curr Opin Oncol 18 16 22 10.1097/01.cco.0000198019.53606.2b 16357559 (Pubitemid 43740445)
7. MH Tan C Morrison P Wang, et al. 2004 Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma Clin Cancer Res 10 6629 6637 10.1158/1078-0432.CCR-04-0493 1:CAS:528: DC%2BD2cXot1Oiu7s%3D 15475453 (Pubitemid 39346560)
8. AJ Gill A Clarkson O Gimm, et al. 2006 Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias Am J Surg Pathol 30 1140 1149 16931959
9. JD Carpten CM Robbins A Villablanca, et al. 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome Nat Genet 32 676 680 10.1038/ng1048 1:CAS:528:DC%2BD38XptVShurk%3D 12434154 (Pubitemid 35435184)
10. VM Howell CJ Haven K Kahnoski, et al. 2003 HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours J Med Genet 40 657 663 10.1136/jmg.40.9.657 1:CAS:528:DC%2BD3sXot1yit7c%3D 12960210
11. TM Shattuck S Välimäki T Obara, et al. 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma N Engl J Med 349 1722 1729 10.1056/NEJMoa031237 1:CAS:528:DC%2BD3sXos1Smsbg%3D 14585940 (Pubitemid 37315009)
12. LJ Krebs TM Shattuck A Arnold 2005 HRPT2 mutational analysis of typical sporadic parathyroid adenomas J Clin Endocrinol Metab 90 5015 5017 10.1210/jc.2005-0717 1:CAS:528:DC%2BD2MXhtVWkur7O 15956079 (Pubitemid 41262247)
13. F Cetani E Pardi S Borsari, et al. 2004 Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors J Clin Endocrinol Metab 89 5583 5591 10.1210/jc.2004-0294 1:CAS:528:DC%2BD2cXhtVSisbvM 15531515 (Pubitemid 39518444)
14. MS Sarquis LG Silveira FJ Pimenta, et al. 2008 Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations Surgery 143 630 640 10.1016/j.surg.2007. 12.012 18436011
15. CJ Haven VM Howell PH Eilers, et al. 2004 Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype Cancer Res 64 7405 7411 10.1158/0008-5472.CAN-04-2063 1:CAS:528:DC%2BD2cXosFyntbo%3D 15492263 (Pubitemid 39372081)
16. C Juhlin A Höög T Yakoleva, et al. 2006 Loss of parafibromin expression in a subset of sporadic parathyroid adenomas Endocr Relat Cancer 13 509 523 10.1677/erc.1.01058 1:CAS:528:DC%2BD28XntF2mtb4%3D 16728578 (Pubitemid 43886673)
17. CC Juhlin A Villablanca K Sandelin, et al. 2007 Parafibromin immunoreactivity-its use as an additional diagnostic marker for parathyroid tumor classification Endocr Relat Cancer 14 501 512 10.1677/ERC-07-0021 1:CAS:528:DC%2BD2sXhtV2lsrrI 17639063 (Pubitemid 47242648)
18. VM Howell A Gill A Clarkson, et al. 2009 Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma J Clin Endocrinol Metab 94 434 441 10.1210/jc.2008-1740 1:CAS:528:DC%2BD1MXhvFCqsL0%3D 19017757
19. CC Juhlin F Haglund A Villablanca, et al. 2009 Loss of expression for the Wnt pathway components adenomatous polyposis coli (APC) and glycogen synthase kinase 3-β (GSK3-β) in parathyroid carcinomas Int J Oncol 34 481 492 1:CAS:528:DC%2BD1MXisVGis7Y%3D 19148484
20. Y Miyoshi H Ando H Nagase, et al. 1992 Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients Proc Natl Acad Sci U S A 89 4452 6 10.1073/pnas.89.10.4452 1:CAS:528:DyaK38Xkt1Cjsrw%3D 1316610
21. C Kraus J Reina-Sanchez Z Suleková WG Ballhausen 1996 Immunochemical identification of novel high-molecular-weight protein isoforms of the adenomatous polyposis coli (APC) gene Int J Cancer 65 383 388 10.1002/(SICI)1097-0215(19960126)65:3<383::AID-IJC18>3.0.CO;2-B 1:CAS:528:DyaK28Xhs1ShsLo%3D 8575862 (Pubitemid 26059145)
22. P Björklund G Åkerström G Westin 2007 Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors J Clin Endocrinol Metab 92 338 344 10.1210/jc.2006-1197 17047023 (Pubitemid 46067551)
23. H Battifora 1991 Assessment of antigen damage in immunohistochemistry. The vimentin internal control Am J Clin Pathol 96 669 671 1:STN:280: DyaK38%2FlvVyntQ%3D%3D 1719801